USBC— USBC, Inc.

Health Care$132M mkt cap

Metric	FY2025	FY2025	FY2024	FY2024
RESEARCH AND DEVELOPMENT EXPENSES	$254K-85.5%	$1.8M+118.5%	$802K-86.9%	$6.1M
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	$16.9M+3.6%	$16.3M+729.1%	$2.0M-78.4%	$9.1M
Total operating expenses	$17.1M-5.1%	$18.0M+552.2%	$2.8M-81.8%	$15.2M
OPERATING LOSS	-$17.1M+5.1%	-$18.0M-552.2%	-$2.8M+81.8%	-$15.2M
Interest income	$38K-42.2%	$66K+379.5%	$14K-91.1%	$155K
Interest expense	-$11K+99.6%	-$2.8M-139.4%	-$1.2M+21.8%	-$1.5M
Loss on debt settlements, net	$0+100.0%	-$942K-29.4%	-$728K	$0
Change in fair value of digital assets	-$27.2M-3203.9%	-$823K	$0	$0
Other derivative income, net	$1.1M+288.8%	$283K	$0	$0
Total other expense, net	-$26.1M-513.3%	-$4.2M-123.9%	-$1.9M-39.8%	-$1.4M
LOSS BEFORE INCOME TAXES	-$43.2M-93.7%	-$22.3M-377.9%	-$4.7M+71.9%	-$16.6M
Income tax benefit	-$15.7M-9004.6%	-$173K	$0	$0
NET LOSS	-$27.5M-24.1%	-$22.1M-374.2%	-$4.7M+71.9%	-$16.6M
Deemed dividends on Series C, D and H Preferred Stock	$0+100.0%	-$2.2M-6752.4%	-$33K+89.6%	-$314K
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	-$27.5M-12.7%	-$24.4M-418.4%	-$4.7M+72.2%	-$16.9M
Basic and diluted loss per share	-$0.07+82.1%	-$0.39-875.0%	-$0.04+99.5%	-$7.85
Weighted average shares of common stock outstanding- basic and diluted (1)	388.1M+515.6%	63.1M-41.9%	108.5M+4941.1%	2.2M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 15 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.